Alsop, Hugh William
- Kinoxis Therapeutics Pty Ltd (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,331
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2019 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.1M
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#3,331
By linked amount among FY2023 PIs
Earliest Year Loaded
2019
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Alsop, Hugh William as a PI. Multi-PI records show the full award amount for context.
- 4UH3DA048743-02UH3Contact PIAdvancing KNX100 for the treatment of opioid withdrawal: preclinical efficacy and toxicology, and a phase 1 clinical program.$2.1Maward amount
Award organization
Organizations that administered FY2023 awards listing Alsop, Hugh William as a PI.
FY2023 award administered by Kinoxis Therapeutics Pty Ltd ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2019First NIH AwardKinoxis Therapeutics Pty Ltd
- 2019$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019$2M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #1800
- 2019Entered Top 25% NationallyRanked #1800
- 2019Entered Top 10% NationallyRanked #1800